Literature DB >> 6790576

Sequential treatments of premature lambs with an artificial surfactant and natural surfactant.

M Ikegami, A Jobe, H Jacobs, S J Jones.   

Abstract

To test an artificial surfactant in vivo, six 120-d gestational age lambs were treated at birth with a mixture of a 9:1 M ratio of [14C]dipalmitoyl phosphatidylcholine (DPC) and phosphatidylglycerol at a dose of 100 mg DPC/kg. Nine other lambs were not treated. The mean PO2 values of the lambs treated with artificial surfactant were 65.7 +/- 11 mm Hg vs. 24.8 +/- 1.6 mm Hg for the untreated lambs (P less than 0.001). All lambs then were treated with 50 mg/natural surfactant lipid per kg, which promptly improved PO2 in all lambs. The PO2 values of those lambs previously treated with artificial surfactant remained greater than 100 mm Hg for 2.5 +/- 0.5 h vs. 0.9 +/- 0.3 h for lambs untreated with artificial surfactant (P less than 0.01). The pH and PCO2 values were not strikingly different between the two groups of lambs. Airway samples taken from lambs treated with artificial surfactant before treatment with natural surfactant had minimal surface tensions of 32 +/- 2.9 dyn/cm, whereas the artificial surfactant reisolated from these samples by centrifugation had minimum surface tension of 0 dyn/cm. The minimum surface tension of artificial surfactant was inhibited by fetal lung fluid from the premature lambs, whereas the minimum surface tension of natural surfactant was much less sensitive to inhibition. Artificial surfactant did not improve the pressure-volume characteristics of unventilated premature lung, whereas natural surfactant did. The change in specific activity of [14C]DPC following treatment with natural surfactant indicated that approximately 50% of the DPC initially administered was no longer associated with the airways.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6790576      PMCID: PMC370823          DOI: 10.1172/jci110280

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

1.  SURFACE PROPERTIES AND LIPIDS FROM LUNGS OF INFANTS WITH HYALINE MEMBRANE DISEASE.

Authors:  F H ADAMS; T FUJIWARA; G EMMANOUILIDES; A SCUDDER
Journal:  J Pediatr       Date:  1965-02       Impact factor: 4.406

2.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

3.  Surface properties in relation to atelectasis and hyaline membrane disease.

Authors:  M E AVERY; J MEAD
Journal:  AMA J Dis Child       Date:  1959-05

4.  Restoration of volume-pressure curves with a lecithin fog.

Authors:  D C Shannon; H Kazemi; E W Merrill; K A Smith; P S Wong
Journal:  J Appl Physiol       Date:  1970-04       Impact factor: 3.531

5.  Pressure-volume relationship of a model alveolus.

Authors:  M Nozaki
Journal:  Tohoku J Exp Med       Date:  1970-07       Impact factor: 1.848

6.  Dry artificial lung surfactant and its effect on very premature babies.

Authors:  C J Morley; A D Bangham; N Miller; J A Davis
Journal:  Lancet       Date:  1981-01-10       Impact factor: 79.321

7.  Surfactant for hyaline membrane disease.

Authors:  T Fujiwara; F H Adams
Journal:  Pediatrics       Date:  1980-11       Impact factor: 7.124

8.  Neonatal pulmonary ischemia. I. Clinical and physiological studies.

Authors:  J Chu; J A Clements; E K Cotton; M H Klaus; A Y Sweet; W H Tooley; B L Bradley; L C Brandorff
Journal:  Pediatrics       Date:  1967-10       Impact factor: 7.124

9.  Artificial surfactant and natural surfactant. Comparative study of the effects on premature rabbit lungs.

Authors:  C Morley; B Robertson; B Lachmann; R Nilsson; A Bangham; G Grossmann; N Miller
Journal:  Arch Dis Child       Date:  1980-10       Impact factor: 3.791

10.  Phosphatidylglycerol in lung surfactant. III. Possible modifier of surfactant function.

Authors:  M Hallman; L Gluck
Journal:  J Lipid Res       Date:  1976-05       Impact factor: 5.922

View more
  6 in total

Review 1.  Surfactant replacement therapy.

Authors:  M J Kresch; W H Lin; R S Thrall
Journal:  Thorax       Date:  1996-11       Impact factor: 9.139

2.  Effects of artificial surfactant on lung function and blood gases in idiopathic respiratory distress syndrome.

Authors:  A D Milner; H Vyas; I E Hopkin
Journal:  Arch Dis Child       Date:  1983-06       Impact factor: 3.791

3.  Surfactant and pulmonary blood flow distributions following treatment of premature lambs with natural surfactant.

Authors:  A Jobe; M Ikegami; H Jacobs; S Jones
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

4.  Advances in respiratory distress syndrome.

Authors:  N R Robertson
Journal:  Br Med J (Clin Res Ed)       Date:  1982-03-27

5.  In vivo evaluation of the inhibitory capacity of human plasma on exogenous surfactant function.

Authors:  B Lachmann; E P Eijking; K L So; D Gommers
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

6.  Effects of bovine surfactant in premature lambs after intra-tracheal application.

Authors:  L Gortner; F Pohlandt; B Disse; E Weller
Journal:  Eur J Pediatr       Date:  1990-01       Impact factor: 3.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.